KIORA PHARMACEUTICALS, INC. (KPRX) Return on equity 2018–2025
KIORA PHARMACEUTICALS, INC. (KPRX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-0.1%FY2025 · since FY2018: -121.0% → -0.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -0.1% | -0.1 pp |
| FY2024 | 0.0% | +0.2 pp |
| FY2023 | -0.2% | — |
| FY2021 | -94.5% | -23.9 pp |
| FY2020 | -70.5% | +36.6 pp |
| FY2019 | -107.2% | +13.8 pp |
| FY2018 | -121.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice